Edition:
United Kingdom

T2 Biosystems Inc (TTOO.OQ)

TTOO.OQ on NASDAQ Stock Exchange Global Market

4.51USD
23 Feb 2018
Change (% chg)

$0.30 (+7.13%)
Prev Close
$4.21
Open
$4.23
Day's High
$4.52
Day's Low
$4.05
Volume
135,681
Avg. Vol
43,656
52-wk High
$6.97
52-wk Low
$2.51

Chart for

About

T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including... (more)

Overall

Beta: --
Market Cap(Mil.): $157.07
Shares Outstanding(Mil.): 35.14
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.19 16.60
EPS (TTM): -- -- --
ROI: -- 13.90 10.66
ROE: -- 16.72 14.30

BRIEF-T2 Biosystems Says John Sprague Has Been Named CFO

* T2 BIOSYSTEMS INC - JOHN SPRAGUE HAS BEEN NAMED CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage:

05 Feb 2018

BRIEF-T2 Biosystems CFO Darlene Deptula-Hicks Resigns

* T2 BIOSYSTEMS- ON JAN 30, DARLENE DEPTULA-HICKS NOTIFIED CO OF HER RESIGNATION FROM POSITION AS CO'S CHIEF FINANCIAL OFFICER EFFECTIVE IMMEDIATELY

05 Feb 2018

BRIEF-T2 Biosystems Says ‍Total Q4 Revenue Is Expected To Exceed Previously Guided Range Of $1.1 Mln To $1.3 Mln​

* T2 BIOSYSTEMS ANNOUNCES PRELIMINARY FOURTH QUARTER 2017 FINANCIAL RESULTS AND PROVIDES UPDATE ON T2BACTERIA PANEL

04 Jan 2018

BRIEF-T2 Biosystems, SMC Ltd Amend Certain Supply Agreement

* T2 BIOSYSTEMS-ON DEC. 22, CO,SMC, LTD ENTERED INTO SECOND AMENDMENT TO SUPPLY AGREEMENT, AMENDING CERTAIN SUPPLY AGREEMENT, DATED AS OF OCT. 10, 2014

27 Dec 2017

BRIEF-T2 Biosystems Q3 loss per share $0.45

* T2 biosystems reports third quarter 2017 financial results and provides company update

02 Nov 2017

BRIEF-T2 Biosystems announces pricing of public offering of common stock

* T2 Biosystems announces pricing of public offering of common stock

15 Sep 2017

BRIEF-T2 Biosystems announces proposed public offering of common stock

* T2 Biosystems announces proposed public offering of common stock Source text for Eikon: Further company coverage:

14 Sep 2017

BRIEF-T2 Biosystems submits 510(K) application to the FDA for review of T2Bacteria Panel

* T2 Biosystems submits 510(K) application to the FDA for review of T2Bacteria Panel‍​ Source text for Eikon: Further company coverage:

11 Sep 2017

BRIEF-T2 Biosystems to collaborate with CDC to detect emerging superbug Candida Auris​

* T2 Biosystems Inc - ‍announces collaboration with CDC to detect emerging superbug Candida Auris​ Source text for Eikon: Further company coverage:

06 Sep 2017

BRIEF-T2 Biosystems entered into amendment to supply agreement as of Oct 10, 2014

* On August 29, Co & Smc Ltd entered into amendment to supply agreement amending certain supply agreement, dated as of Oct 10, 2014

05 Sep 2017

Earnings vs. Estimates